Among the target genes in MrGPS, CYP17A1 is up-regulated in gliomas, playing a role in mediating glioma cell invasiveness and contributing to resistance against TMZ-induced cytotoxicity [64]. The gene discussed is CYP17A1; the disease is central nervous system cancer.